Acceleron Pharma Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Acceleron Pharma Inc.
Quantité totale PI 359
Rang # Quantité totale PI 3 656
Note d'activité PI 3,1/5.0    159
Rang # Activité PI 4 204
Symbole boursier XLRN (nasdaq)
ISIN US00434H1086
Capitalisation 6,900M  (USD)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

205 0
55 0
99 0
0
 
Dernier brevet 2025 - Novel binders of tgfb-superfamil...
Premier brevet 2005 - Alk7 and myostatin inhibitors an...

Derniers inventions, produits et services

2025 Invention Actrii proteins for the treatment of pulmonary arterial hypertension (pah). In some aspects, the...
Invention Compositions and methods for treating pulmonary hypertension. In some aspects, the disclosure re...
Invention Alk4:actriib heteromultimers and uses thereof. In certain aspects, the disclosure provides solub...
2024 Invention Tgf-beta receptor type ii fusion proteins and uses thereof. In certain aspects, the present disc...
Invention Actrii proteins and use in treating post-capillary pulmonary hypertension. In some aspects, the ...
Invention Actriib binding agents and uses thereof. The disclosure provides, among other aspects, neutraliz...
Invention Novel binders of tgfb-superfamily ligands and uses thereof. In certain aspects, the disclosure p...
Invention Multispecific binders of tgfbeta-superfamily ligands and uses thereof. In certain aspects, the d...
Invention Activin type 2 receptor binding proteins and methods of making them. This disclosure provides Ac...
Invention Alk7 antagonists and uses thereof. In certain aspects, the disclosure provides ALK7 antagonists....
Invention Methods for treating myeloproliferative disorders. In part, the present disclosure relates metho...
Invention Alk7 binding proteins and uses thereof. This disclosure provides ALK7-binding proteins such as a...
Invention Compositions and methods for treating pulmonary hypertension. In some aspects, the invention tea...
Invention Method for promoting bone growth using activin-actriia antagonists. In certain aspects, the pres...
2023 Invention Compositions and methods for treating spinal muscular atrophy. In certain aspects, the disclosur...
Invention Tgf-beta superfamily type i and type ii receptor heteromultimers and uses thereof. In certain as...
Invention Treatments for complications associated with chronic liver disease. In certain aspects, the pres...
Invention Treatments for hermansky-pudlak syndrome. In certain aspects, the present disclosure relates to ...
Invention Twisted gastrulation polypeptides and uses thereof. In certain aspects, the present invention pro...
2022 Invention Compositions and methods for treating pulmonary hypertension. In some aspects, the disclosure rel...
Invention Activin-actrii antagonists and uses for treating anemia. Provided herein are methods for the tre...
Invention Tgf-beta superfamily type i and type ii receptor heteromultimers and uses thereof. In certain asp...
Invention Compositions and methods for treating renal diseases or conditions. In some aspects, the disclos...
Invention Compositions and methods for treating renal diseases or conditions. In some aspects, the disclosu...
Invention Actrii proteins and uses thereof. In some aspects, the disclosure relates to compositions and me...
Invention Actrii proteins and uses thereof. In some aspects, the disclosure relates to compositions and met...
Invention Actrii proteins and uses thereof. e.g.e.g.e.g., pulmonary hypertension associated with chronic ob...
Invention Actrii-alk4 antagonists and methods of treating heart failure. In some aspects, the disclosure r...
2021 Invention Formulations comprising actrii polypeptide variants. In certain aspects, the present disclosure ...
Invention Single-arm actriia and actriib heteromultimers and methods for treating renal diseases or conditi...
Invention Variant actriib proteins and uses thereof. In certain aspects, the present invention provides no...
2020 Invention Single-arm actriia and actriib heteromultimers and methods for treating pulmonary hypertension. ...
Invention Treatments for systemic sclerosis. In certain aspects, the present disclosure relates to methods...